Assenagon Asset Management
RCEL icon

Assenagon Asset Management’s Avita Medical RCEL Stock Holding History

Assenagon Asset Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-67,364
Closed -$984K – 1476
2023
Q3 		$984K Sell
67,364
-23,620
-26% -$400K ﹤0.01% 1046
2023
Q2 		$1.55M Buy
90,984
+30,137
+50% +$442K 0.01% 858
2023
Q1 		$850K Buy
60,847
+44,477
+272% +$473K ﹤0.01% 1099
2022
Q4 		$108K Sell
16,370
-17,123
-51% -$103K ﹤0.01% 1332
2022
Q3 		$177K Buy
+33,493
New +$207K ﹤0.01% 1280

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Assenagon Asset Management's RCEL Position: Q4 2023 in Review

Assenagon Asset Management sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 67,364 shares — an estimated $984K sold.

Assenagon Asset Management first reported a position in RCEL in Q3 2022 and held it in 5 quarters. The position peaked at $1.55M in Q2 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

  • Assenagon Asset Management reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 67,364 Avita Medical shares in Q4 2023, an estimated $984K.
  • Assenagon Asset Management first reported a position in Avita Medical in Q3 2022 and held it in 5 quarters.
  • Assenagon Asset Management's Avita Medical position peaked at $1.55M in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on Assenagon Asset Management's 13F filing for Q4 2023, filed 17 Jan 2024.